about
Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density LipoproteinA Trial of Lifestyle Modification on Cardiopulmonary, Inflammatory, and Metabolic Effects among Obese with Chronic Kidney Disease.Metabolic syndrome, serum uric acid and renal risk in patients with T2D.Risks of decreased renal function and increased albuminuria for glycemic status and metabolic syndrome components: Taichung Community Health study.Adiposity measures, lean body mass, physical activity and mortality: NHANES 1999-2004.Metabolic syndrome and chronic kidney disease: Current status and future directions.Obesity, metabolic health, and the risk of end-stage renal disease.Abdominal Obesity and Mortality in Continuous Ambulatory Peritoneal Dialysis Patients.Body mass index and causes of death in chronic kidney disease.Mortality Outcomes of Patients with Chronic Kidney Disease and Chronic Obstructive Pulmonary Disease.Body mass index is inversely associated with mortality in patients with acute kidney injury undergoing continuous renal replacement therapy.HDL cholesterol is not associated with lower mortality in patients with kidney dysfunction.Increased body mass index is a risk factor for end-stage renal disease in the Chinese Singapore population.Prevalence and determinants of the metabolic syndrome among subjects with advanced nondiabetes-related chronic kidney disease in Gran Canaria, Spain.Relative contributions of testosterone deficiency and metabolism syndrome at the risk of reduced quality of life: A cross-sectional study among Chinese mid-aged and elderly men.Long-term risk for end-stage kidney disease and death in a large population-based cohort.Metabolic Syndrome Severity and Risk of CKD and Worsened GFR: The Jackson Heart StudyEstrogen receptor 1 gene polymorphisms are associated with metabolic syndrome in postmenopausal women in China
P2860
Q28083619-164AAE38-AEFF-4C12-9A74-95B601A9076AQ30355733-669C3548-6CD5-44D5-B12A-82DDE805C2C9Q33579624-E7A98C47-903F-41AC-B2B5-D84BEE838A33Q33679189-209450EA-399C-4CD7-88A5-E9024745AF47Q33905938-DBDF6559-7BD6-4E35-A014-733DF7C6658EQ34453266-84461A3F-A047-44C1-A2B1-5F8BA23E9DDFQ35667706-65D6B22A-F920-4441-A69F-1611CF3B09DAQ35904961-214C0F28-4F9C-4E14-833B-1F036ABB5A87Q36591446-BDC06541-6CF4-46B1-8AAB-7A1A94A15A15Q36692766-A604CEA2-A2B0-473E-8E94-820F1376DE94Q37674127-EE2AA5B1-9027-44EE-B076-DCD1F0DB16EFQ37733566-D87F838F-2377-4DBB-9CAE-20503A0F7CC6Q40192525-ABC2A2EB-0AB7-45FE-9ADC-7F13E9DDF3AEQ41081436-7C3C9E01-F7AA-4388-997E-6FE326B5B93AQ48005331-99D84FED-67CA-4470-A755-6EE8E23B91CEQ55223580-BF634838-B611-46BF-8839-ED4FB3ED592CQ56394611-26FAF9CD-2511-42E7-9CE5-F7CD3C993A39Q58741440-DF958631-7B56-4EB4-9C20-D09AF3BE74CF
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Metabolic syndrome, ESRD, and death in CKD.
@en
type
label
Metabolic syndrome, ESRD, and death in CKD.
@en
prefLabel
Metabolic syndrome, ESRD, and death in CKD.
@en
P2093
P2860
P356
P1476
Metabolic syndrome, ESRD, and death in CKD.
@en
P2093
Emilio D Poggio
Jesse D Schold
John P Kirwan
Joseph V Nally
Sankar D Navaneethan
Srinivasan Beddhu
Stacey E Jolly
Susana Arrigain
P2860
P304
P356
10.2215/CJN.09870912
P577
2013-02-14T00:00:00Z